Probiotics, Antibiotics and the Post-Antibiotic Microbiota
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorCultech Ltd
About this trial
Antibiotic therapy can cause gastrointestinal dysbiosis and this study will assess the impact of probiotic supplementation on microbiological composition and functionality pre- and post- antibiotic therapy
Eligibility criteria
Qualifiers
Adults, aged 18-40.
Been prescribed an oral dose of cephalosporin antibiotic lasting 5 - 10 days.
Willing to provide stool samples and, for women, vaginal samples.
Willing to avoid consumption of any other probiotic capsules/tablets during the study.
Disqualifiers
If antibiotics prescribed are intended to treat any gastrointestinal or vaginally related issue.
Any antibiotic intake within the last 3 months.
Immunodeficient or undergoing immunosuppressive therapy.
Currently diagnosed with diabetes/cardiovascular disease/cancer/dementia.
Trial design
Treatments tested in this trial
- Lab4S
- Placebo
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov